Selected research
Market Structure
Global Weight Loss and Obesity Management Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Weight Loss and Obesity Management market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Weight Loss and Obesity Management is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Weight Loss and Obesity Management include Eisai, Johnson & Johnson, Novo Nordisk, Medtronic, Roche, GlaxoSmithKline, Vivus Inc, ReShape Lifesciences and Obalon Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Weight Loss and Obesity Management market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Weight Loss and Obesity Management and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Weight Loss and Obesity Management revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Weight Loss and Obesity Management market size, projected growth trends, production technologies, key applications, and end-use industries.
Weight Loss and Obesity Management Segment by Company
Eisai
Johnson & Johnson
Novo Nordisk
Medtronic
Roche
GlaxoSmithKline
Vivus Inc
ReShape Lifesciences
Obalon Therapeutics
Nalpropion Pharmaceuticals
Beijing Noble Laser Technology
Allurion Technologies
Allergan
Weight Loss and Obesity Management Segment by Type
Weight Loss and Obesity Management Devices
Weight Loss and Obesity Management Drugs
Weight Loss and Obesity Management Segment by Application
Men
Women
Weight Loss and Obesity Management Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Weight Loss and Obesity Management market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Weight Loss and Obesity Management and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Weight Loss and Obesity Management.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Weight Loss and Obesity Management in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Weight Loss and Obesity Management industry.
Chapter 3: Detailed analysis of Weight Loss and Obesity Management companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Weight Loss and Obesity Managementrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Weight Loss and Obesity Management Devices
- Weight Loss and Obesity Management Drugs
Applications
- Men
- Women
Companies covered
- Eisai
- Johnson & Johnson
- Novo Nordisk
- Medtronic
- Roche
- GlaxoSmithKline
- Vivus Inc
- ReShape Lifesciences
- Obalon Therapeutics
- Nalpropion Pharmaceuticals
- Beijing Noble Laser Technology
- Allurion Technologies
- Allergan
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Weight Loss and Obesity Management Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Weight Loss and Obesity Management Devices
- 1.2.3 Weight Loss and Obesity Management Drugs
- 1.3 Market Analysis by Application
- 1.3.1 Global Weight Loss and Obesity Management Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Men
- 1.3.3 Women
- 1.4 Global Market Growth Prospects
- 1.5 Global Weight Loss and Obesity Management Growth Trends by Region
- 1.5.1 Global Weight Loss and Obesity Management Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Weight Loss and Obesity Management Market Size by Region (2021-2026)
- 1.5.3 Weight Loss and Obesity Management Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Weight Loss and Obesity Management Market Dynamics
- 2.1 Weight Loss and Obesity Management Industry Trends
- 2.2 Weight Loss and Obesity Management Industry Drivers
- 2.3 Weight Loss and Obesity Management Industry Opportunities and Challenges
- 2.4 Weight Loss and Obesity Management Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Weight Loss and Obesity Management Revenue by Company (2021-2026)
- 3.2 Global Weight Loss and Obesity Management Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Weight Loss and Obesity Management Key Company Head office and Area Served
- 3.4 Global Weight Loss and Obesity Management Company, Product Type & Application
- 3.5 Global Weight Loss and Obesity Management Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Weight Loss and Obesity Management Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Weight Loss and Obesity Management Players Market Share by Revenue in 2025
- 3.6.3 2025 Weight Loss and Obesity Management Tier 1, Tier 2, and Tier 3
4 Weight Loss and Obesity Management Market by Type
- 4.1 Global Weight Loss and Obesity Management Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Weight Loss and Obesity Management Market Size by Type (2021-2032)
- 4.3 Global Weight Loss and Obesity Management Market Size Share by Type (2021-2032)
5 Weight Loss and Obesity Management Market by Application
- 5.1 Global Weight Loss and Obesity Management Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Weight Loss and Obesity Management Market Size by Application (2021-2032)
- 5.3 Global Weight Loss and Obesity Management Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Eisai
- 6.1.1 Eisai Company Information
- 6.1.2 Eisai Business Overview
- 6.1.3 Eisai Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Eisai Weight Loss and Obesity Management Product Portfolio
- 6.1.5 Eisai Recent Developments
- 6.2 Johnson & Johnson
- 6.2.1 Johnson & Johnson Company Information
- 6.2.2 Johnson & Johnson Business Overview
- 6.2.3 Johnson & Johnson Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Johnson & Johnson Weight Loss and Obesity Management Product Portfolio
- 6.2.5 Johnson & Johnson Recent Developments
- 6.3 Novo Nordisk
- 6.3.1 Novo Nordisk Company Information
- 6.3.2 Novo Nordisk Business Overview
- 6.3.3 Novo Nordisk Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Novo Nordisk Weight Loss and Obesity Management Product Portfolio
- 6.3.5 Novo Nordisk Recent Developments
- 6.4 Medtronic
- 6.4.1 Medtronic Company Information
- 6.4.2 Medtronic Business Overview
- 6.4.3 Medtronic Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 Medtronic Weight Loss and Obesity Management Product Portfolio
- 6.4.5 Medtronic Recent Developments
- 6.5 Roche
- 6.5.1 Roche Company Information
- 6.5.2 Roche Business Overview
- 6.5.3 Roche Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Roche Weight Loss and Obesity Management Product Portfolio
- 6.5.5 Roche Recent Developments
- 6.6 GlaxoSmithKline
- 6.6.1 GlaxoSmithKline Company Information
- 6.6.2 GlaxoSmithKline Business Overview
- 6.6.3 GlaxoSmithKline Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 GlaxoSmithKline Weight Loss and Obesity Management Product Portfolio
- 6.6.5 GlaxoSmithKline Recent Developments
- 6.7 Vivus Inc
- 6.7.1 Vivus Inc Company Information
- 6.7.2 Vivus Inc Business Overview
- 6.7.3 Vivus Inc Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Vivus Inc Weight Loss and Obesity Management Product Portfolio
- 6.7.5 Vivus Inc Recent Developments
- 6.8 ReShape Lifesciences
- 6.8.1 ReShape Lifesciences Company Information
- 6.8.2 ReShape Lifesciences Business Overview
- 6.8.3 ReShape Lifesciences Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 ReShape Lifesciences Weight Loss and Obesity Management Product Portfolio
- 6.8.5 ReShape Lifesciences Recent Developments
- 6.9 Obalon Therapeutics
- 6.9.1 Obalon Therapeutics Company Information
- 6.9.2 Obalon Therapeutics Business Overview
- 6.9.3 Obalon Therapeutics Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 Obalon Therapeutics Weight Loss and Obesity Management Product Portfolio
- 6.9.5 Obalon Therapeutics Recent Developments
- 6.10 Nalpropion Pharmaceuticals
- 6.10.1 Nalpropion Pharmaceuticals Company Information
- 6.10.2 Nalpropion Pharmaceuticals Business Overview
- 6.10.3 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 Nalpropion Pharmaceuticals Weight Loss and Obesity Management Product Portfolio
- 6.10.5 Nalpropion Pharmaceuticals Recent Developments
- 6.11 Beijing Noble Laser Technology
- 6.11.1 Beijing Noble Laser Technology Company Information
- 6.11.2 Beijing Noble Laser Technology Business Overview
- 6.11.3 Beijing Noble Laser Technology Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Beijing Noble Laser Technology Weight Loss and Obesity Management Product Portfolio
- 6.11.5 Beijing Noble Laser Technology Recent Developments
- 6.12 Allurion Technologies
- 6.12.1 Allurion Technologies Company Information
- 6.12.2 Allurion Technologies Business Overview
- 6.12.3 Allurion Technologies Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Allurion Technologies Weight Loss and Obesity Management Product Portfolio
- 6.12.5 Allurion Technologies Recent Developments
- 6.13 Allergan
- 6.13.1 Allergan Company Information
- 6.13.2 Allergan Business Overview
- 6.13.3 Allergan Weight Loss and Obesity Management Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Allergan Weight Loss and Obesity Management Product Portfolio
- 6.13.5 Allergan Recent Developments
7 North America
- 7.1 North America Weight Loss and Obesity Management Market Size (2021-2032)
- 7.2 North America Weight Loss and Obesity Management Market Size by Type
- 7.2.1 North America Weight Loss and Obesity Management Market Size by Type (2021-2026)
- 7.2.2 North America Weight Loss and Obesity Management Market Size by Type (2027-2032)
- 7.2.3 North America Weight Loss and Obesity Management Market Share by Type (2021-2032)
- 7.3 North America Weight Loss and Obesity Management Market Size by Application
- 7.3.1 North America Weight Loss and Obesity Management Market Size by Application (2021-2026)
- 7.3.2 North America Weight Loss and Obesity Management Market Size by Application (2027-2032)
- 7.3.3 North America Weight Loss and Obesity Management Market Share by Application (2021-2032)
- 7.4 North America Weight Loss and Obesity Management Market Size by Country
- 7.4.1 North America Weight Loss and Obesity Management Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 7.4.3 North America Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 7.4.4 North America Weight Loss and Obesity Management Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Weight Loss and Obesity Management Market Size (2021-2032)
- 8.2 Europe Weight Loss and Obesity Management Market Size by Type
- 8.2.1 Europe Weight Loss and Obesity Management Market Size by Type (2021-2026)
- 8.2.2 Europe Weight Loss and Obesity Management Market Size by Type (2027-2032)
- 8.2.3 Europe Weight Loss and Obesity Management Market Share by Type (2021-2032)
- 8.3 Europe Weight Loss and Obesity Management Market Size by Application
- 8.3.1 Europe Weight Loss and Obesity Management Market Size by Application (2021-2026)
- 8.3.2 Europe Weight Loss and Obesity Management Market Size by Application (2027-2032)
- 8.3.3 Europe Weight Loss and Obesity Management Market Share by Application (2021-2032)
- 8.4 Europe Weight Loss and Obesity Management Market Size by Country
- 8.4.1 Europe Weight Loss and Obesity Management Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 8.4.3 Europe Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 8.4.4 Europe Weight Loss and Obesity Management Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Weight Loss and Obesity Management Market Size (2021-2032)
- 9.2 China Weight Loss and Obesity Management Market Size by Type
- 9.2.1 China Weight Loss and Obesity Management Market Size by Type (2021-2026)
- 9.2.2 China Weight Loss and Obesity Management Market Size by Type (2027-2032)
- 9.2.3 China Weight Loss and Obesity Management Market Share by Type (2021-2032)
- 9.3 China Weight Loss and Obesity Management Market Size by Application
- 9.3.1 China Weight Loss and Obesity Management Market Size by Application (2021-2026)
- 9.3.2 China Weight Loss and Obesity Management Market Size by Application (2027-2032)
- 9.3.3 China Weight Loss and Obesity Management Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Weight Loss and Obesity Management Market Size (2021-2032)
- 10.2 Asia Weight Loss and Obesity Management Market Size by Type
- 10.2.1 Asia Weight Loss and Obesity Management Market Size by Type (2021-2026)
- 10.2.2 Asia Weight Loss and Obesity Management Market Size by Type (2027-2032)
- 10.2.3 Asia Weight Loss and Obesity Management Market Share by Type (2021-2032)
- 10.3 Asia Weight Loss and Obesity Management Market Size by Application
- 10.3.1 Asia Weight Loss and Obesity Management Market Size by Application (2021-2026)
- 10.3.2 Asia Weight Loss and Obesity Management Market Size by Application (2027-2032)
- 10.3.3 Asia Weight Loss and Obesity Management Market Share by Application (2021-2032)
- 10.4 Asia Weight Loss and Obesity Management Market Size by Country
- 10.4.1 Asia Weight Loss and Obesity Management Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 10.4.3 Asia Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 10.4.4 Asia Weight Loss and Obesity Management Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Weight Loss and Obesity Management Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Type
- 11.2.1 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Weight Loss and Obesity Management Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Application
- 11.3.1 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Weight Loss and Obesity Management Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Country
- 11.4.1 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Weight Loss and Obesity Management Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Weight Loss and Obesity Management Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst